Activation of the hiv long terminal repeat and viral production by H2O2-vanadate

Free Radical Biology and Medicine

Volumn 20, Issue 6, 1996, Pages 813-820

  Kazazi, Farhad ^a   Koehler, James K ^a   Klebanoff, Seymour J ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

1G5; Free radical; H2O2; HIV; Jurkat; Long terminal repeat; THP 1; U 1; Vanadate

Indexed keywords

FREE RADICAL; HYDROGEN PEROXIDE; VANADIC ACID;

ARTICLE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS REPLICATION;

CATALASE; DRUG SYNERGISM; GENES, REPORTER; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; HYDROGEN PEROXIDE; LUCIFERASES; MICROSCOPY, ELECTRON; STAPHYLOCOCCUS EPIDERMIDIS; TUMOR CELLS, CULTURED; VANADATES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0029863314     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(95)02214-7     Document Type: Article

References (36)

1. Chinnadurai, G. Modulation of HIV-enhancer activity by heterologous agents: A minireview. Gene 101:165-170; 1991.
2. Cullen, B. R. Regulation of HIV-1 gene expression. FASEB J. 5:2361-2368; 1991.
3. Legrand-Poels, S.; Varia, D.; Pincemail, J.; Van de Vorst, A.; Piette, J. Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res. Hum. Retroviruses 6:1389-1397; 1990.
4. Schreck, R.; Rieber, P.; Baeuerle, P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10:2247-2258; 1991.
5. Ramasarma, T.; Crane, F. L. Does vanadium play a role in cellular regulation? Curr. Top. Cell. Regul. 20:247-301; 1981.
6. Chasteen, N. D. The biochemistry of vanadium. Struct. Bond. 53:105-138; 1983.
7. Nechay, B. R.; Nanninga, L. B.; Nechay, P. S. E.; Post, R. L.; Grantham, J. J.; Macara, I. G.; Kubena, L. F.; Phillips, T. D.; Nielsen, F. H. Role of vanadium in biology. Fed. Proc. 45:123-132; 1986.
8. +) ATPase inhibitor. J. Biol. Chem. 255:5306-5312; 1980.
9. Shechter, Y.; Karlish, S. J. D. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284:556-558; 1980.
10. Shechter, Y. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 39:1-5; 1990.
11. Czech, M. P.; Lawrence, J. C., Jr.; Lynn, W. S. Hexose transport in isolated brown fat cells. A model system for investigating insulin action on membrane transport. J. Biol. Chem. 249:5421-5427; 1974.
12. Czech, M. P.; Lawrence, J. C., Jr.; Lynn, W. S. Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc. Natl. Acad. Sci. USA 71:4173-4177; 1974.
13. Little, S. A.; de Haen, C. Effects of hydrogen peroxide on basal and hormone-stimulated lipolysis in perifused rat fat cells in relation to the mechanism of action of insulin. J. Biol. Chem. 255:10888-10895; 1980.
14. May, J. M.; de Haen, C. The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J. Biol. Chem. 254:9017-9021; 1979.
15. Kadota, S.; Fantus, I. G.; Deragon, G.; Guyda, H. J.; Hersh, B.; Posner, B. I. Peroxide(s) of vanadium: A novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem. Biophys. Res. Commun. 147:259-266; 1987.
16. 2. Mol. Cell. Biochem. 129:9-29; 1993.
17. 2. J. Biol. Chem. 262:8252-8256; 1987.
18. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J. Biol. Chem. 265:2896-2902; 1990.
19. Fantus, I. G.; Kadota, S.; Deragon, G.; Foster, B.; Posner, B. I. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry 28:8864-8871; 1989.
20. Shisheva, A.; Schechter, Y. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: Dissociation from vanadate effect. Endocrinology 133:1562-1568; 1993.
21. Klebanoff, S. J.; Kazazi, F.; Van Voorhis, W. C.; Schlechte, K. G. Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product. Proc. Natl Acad. Sci. USA 91:10615-10619; 1994.
22. Folks, T. M.; Justement, J.; Kinter, A.; Schnittman, S.; Orenstein, J.; Poli, G.; Fauci, A. S. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140:1117-1122; 1988.
23. Luft, J. H. Improvements in epoxy resin embedding methods. J. Biophys. Biochem. Cytol. 9:409-414; 1961.
24. Antoni, B. A.; Stein, S. B.; Rabson, A. B. Regulation of human immunodeficiency virus infection: Implications for pathogenesis. Adv. Virus Res. 43:53-145; 1994.
25. Hopkins, L. L., Jr.; Mohr, H. E. Vanadium as an essential nutrient. Fed. Proc. 33:1773-1775; 1974.
26. Schroeder, H. A.; Balassa, J. J.; Tipton, I. H. Abnormal trace metals in man - vanadium. J. Chron. Dis. 16:1047-1071; 1963.
27. Byrne, A. R.; Kosta, L. Vanadium in foods and in human body fluids and tissues. Sci. Total Environ. 10:17-30; 1978.
28. Nechay, B. R. Mechanisms of action of vanadium. Annu. Rev. Pharmacol. Toxicol. 24:501-524; 1984.
29. Dimond, E. G.; Caravaca, J.; Benchimol, A. Vanadium. Excretion, toxicity, lipid effect in man. Am. J. Clin. Nutr. 12:49-53; 1963.
30. Sakurai, H.; Shimomura, S.; Fukuzawa, K.; Ishizu, K. Detection of oxovanadium (IV) and characterization of its ligand environment in subcellular fractions of the liver of rats treated with pentavalent vanadium (V). Biochem. Biophys. Res. Commun. 96:293-298; 1980.
31. Rubinson, K. A. Concerning the form of biochemically active vanadium. Proc. R. Soc. Lond. [Biol.] 212:65-84; 1981.
32. Swarup, G.; Cohen, S.; Garbers, D. L. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun. 107:1104-1109; 1982.
33. Swarup, G.; Speeg, K. V., Jr.; Cohen, S.; Garbers, D. L. Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J. Biol. Chem. 257:7298-7301; 1982.
34. 2 activation: Potentiation by vanadate. Biochem. J. 295:879-888; 1993.
35. Secrist, J. P.; Burns, L. A.; Karnitz, L.; Koretzky, G. A.; Abraham, R. T. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol Chem. 268:5886-5893; 1993.
36. fyn tyrosine kinases in human lymphocytes. Blood 82:1212-1220; 1993.